| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $465.3M | +16.5% |
| Cost of Revenue | $117.8M | +19.1% |
| Gross Profit | $347.5M | +15.7% |
| R&D Expense | $96.2M | +30.1% |
| SG&A Expense | $291.4M | +15.1% |
| Operating Income | -$40.0M | -50.0% |
| Pre-tax Income | -$43.7M | -46.3% |
| Income Tax | $1.0M | +73.3% |
| Net Income | -$44.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $122.7M | +45.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $60.3M | +14.9% |
| Inventory | $75.3M | +11.0% |
| Current Assets | $267.8M | +0.6% |
| Total Assets | $609.3M | -0.7% |
| Current Liabilities | $73.4M | -1.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.2M | +172.2% |
| Capital Expenditures | $11.5M | -4.5% |
| Investing Cash Flow | $30.2M | +38.6% |
| Financing Cash Flow | -$3.6M | — |
| Free Cash Flow | $745K | +109.9% |
| -46.8% |
| EPS (Basic) | -$0.95 | -43.9% |
| EPS (Diluted) | -$0.95 | -43.9% |
| Long-term Debt |
| $61.9M |
| +0.0% |
| Total Liabilities | $148.4M | +0.4% |
| Stockholders' Equity | $461.0M | -1.1% |